Drugs / EADM
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02630108 Background | Dec 2015 → Dec 2017 | hepatocellular carcinoma | Shanghai Zhongshan Hospital | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EADM | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02630108 ↗ |